For a seamless experience for patients, colonoscopic fecal microbiota transplantation allows for the restoration of gut ...

Fecal microbiota transplantation with an anaerobic cultivated human intestinal microbiome failed to improve gastrointestinal symptoms in patients with systemic sclerosis, a phase 2 study showed.

Hepatic encephalopathy is a liver disease that affects the brain. Learn how a new treatment can treat the disease and prevent ...

End-stage liver disease is associated with disruptions in gut microbiota composition and function, which may facilitate ...

Two cancer patients were successfully treated with fecal microbiota transplants (FMTs) for colitis caused by immunotherapy, according to a case report published today (November 12) in Nature Medicine.

There was improvement in the Irritable Bowel Syndrome Impact Scale score, from 108 to 140 with fecal microbiota transplant and from 77 to 92 with placebo. HealthDay News — For patients with type ...

End-stage liver disease is associated with disruptions in gut microbiota composition and function, which may facilitate ...

More information: Swetha Reddi et al, Fecal microbiota transplantation to prevent acute graft-versus-host disease: pre-planned interim analysis of donor effect, Nature Communications (2025). DOI ...

SEATTLE — Jan. 28, 2025 — A new study shows that oral fecal microbiota transplantation (FMT) is a feasible and safe addition to preventing graft-versus-host disease in patients undergoing stem ...

Phase 2 clinical trial shows a safe dose from a specific donor helped with gut microbiome recovery in people with cancer ...